Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Paramyxoviridae
gptkb:Rubulavirus |
| gptkbp:caused_by |
mumps
|
| gptkbp:complications |
gptkb:psychologist
meningitis hearing loss orchitis oophoritis |
| gptkbp:cultural_impact |
mentioned in historical texts
depicted in literature associated with childhood diseases |
| gptkbp:family |
gptkb:Paramyxoviridae
|
| gptkbp:genus |
gptkb:Morbillivirus
|
| gptkbp:healthcare |
vaccine recommendations
WHO vaccination recommendations |
| gptkbp:historical_event |
first described in the 18th century
|
| gptkbp:hosts |
gptkb:Person
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mumps virus
|
| gptkbp:incubation_period |
16 to 18 days
|
| gptkbp:instrument |
PCR testing
virus isolation antibody detection |
| gptkbp:is_protected_by |
vaccination
|
| gptkbp:is_recognized_by |
1934
|
| gptkbp:is_vulnerable_to |
gptkb:MMR_vaccine
live attenuated vaccine approximately 88% after two doses administered at 12-15 months and 4-6 years introduced in 1967 |
| gptkbp:public_awareness |
importance of vaccination
outbreak prevention strategies symptoms recognition |
| gptkbp:research |
genetic diversity studies
pathogenesis studies immune response studies ongoing studies on vaccine efficacy |
| gptkbp:seed_dispersal |
single-stranded RNA
|
| gptkbp:social_responsibility |
gptkb:rubella_virus
clinical evaluation global distribution serological tests measles virus isolation of infected individuals common in unvaccinated populations quarantine of exposed individuals |
| gptkbp:social_structure |
enveloped virus
|
| gptkbp:symptoms |
fatigue
headache muscle pain fever loss of appetite swelling of salivary glands |
| gptkbp:transmission |
saliva
|
| gptkbp:treatment |
hydration
pain relief supportive care |